tiprankstipranks
Trending News
More News >
Argenica Therapeutics Ltd (AU:AGN)
ASX:AGN
Australian Market

Argenica Therapeutics Ltd (AGN) Ratios

Compare
10 Followers

Argenica Therapeutics Ltd Ratios

AU:AGN's free cash flow for Q2 2025 was AU$1.00. For the 2025 fiscal year, AU:AGN's free cash flow was decreased by AU$ and operating cash flow was AU$-0.52. See a summary of the company’s cash flow.
Ratios
TTM
Jun 24Jun 23Jun 22Jun 21
Liquidity Ratios
Current Ratio
5.09 5.09 12.29 17.08 1.05
Quick Ratio
5.09 5.09 12.39 17.26 1.14
Cash Ratio
4.96 4.96 12.11 16.78 0.95
Solvency Ratio
0.03 0.03 <0.01 <0.01 0.76
Operating Cash Flow Ratio
-1.76 -1.76 -4.57 -2.46 -0.16
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
AU$ 7.67MAU$ 7.67MAU$ 8.31MAU$ 6.85MAU$ 17.40K
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.00 0.00 0.00 0.00
Debt-to-Equity Ratio
0.00 0.00 0.00 0.00 0.00
Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.24 1.24 1.09 1.06 20.53
Debt Service Coverage Ratio
1.31K 1.31K 315.20 -2.70 0.00
Interest Coverage Ratio
-6.31K -6.31K -4.98K -51.47K 0.00
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
<0.01 <0.01 <0.01 <0.01 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00
Profitability Margins
Gross Profit Margin
100.00%100.00%100.00%100.00%0.00%
EBIT Margin
-353.90%-353.90%-1678.84%-447.69%0.00%
EBITDA Margin
0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin
-378.59%-378.59%-1578.53%-347.69%0.00%
Pretax Profit Margin
-353.90%-353.90%-1578.84%-347.70%0.00%
Net Profit Margin
-275.16%-275.16%-1578.84%-347.72%0.00%
Continuous Operations Profit Margin
-275.16%-275.16%-1578.84%-347.72%0.00%
Net Income Per EBT
77.75%77.75%100.00%100.01%100.00%
EBT Per EBIT
93.48%93.48%100.02%100.00%99.94%
Return on Assets (ROA)
-50.47%-50.47%-45.23%-14.16%-101.52%
Return on Equity (ROE)
-62.81%-62.81%-49.24%-15.04%-2084.05%
Return on Capital Employed (ROCE)
-86.41%-86.41%-49.23%-15.04%-2085.39%
Return on Invested Capital (ROIC)
-67.19%-67.19%-46.11%-15.04%1491.89%
Return on Tangible Assets
-50.47%-50.47%-45.24%-14.16%-101.79%
Earnings Yield
-14.66%-14.66%-12.87%-7.03%-2.02%
Efficiency Ratios
Receivables Turnover
11.49 11.49 0.00 0.00 0.00
Payables Turnover
0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.18 0.18 0.03 0.04 0.00
Working Capital Turnover Ratio
0.22 0.22 0.03 0.09 0.00
Cash Conversion Cycle
31.78 31.78 0.00 0.00 0.00
Days of Sales Outstanding
31.78 31.78 0.00 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
0.00 0.00 0.00 0.00 0.00
Operating Cycle
31.78 31.78 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-0.04 -0.04 -0.05 -0.01 >-0.01
Free Cash Flow Per Share
-0.04 -0.04 -0.05 -0.01 >-0.01
CapEx Per Share
0.00 0.00 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
-1.89 -1.89 -12.97 -3.53 0.00
Free Cash Flow Yield
-10.05%-10.05%-10.58%-7.15%-0.31%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-6.82 -6.82 -7.77 -14.22 -49.62
Price-to-Sales (P/S) Ratio
18.77 18.77 122.69 49.43 0.00
Price-to-Book (P/B) Ratio
4.28 4.28 3.83 2.14 1.03K
Price-to-Free Cash Flow (P/FCF) Ratio
-9.95 -9.95 -9.46 -13.99 -323.46
Price-to-Operating Cash Flow Ratio
-9.95 -9.95 -9.46 -13.99 -323.46
Price-to-Earnings Growth (PEG) Ratio
12.57 12.57 -0.03 -0.08 0.00
Price-to-Fair Value
4.28 4.28 3.83 2.14 1.03K
Enterprise Value Multiple
0.00 0.00 0.00 0.00 0.00
Enterprise Value
23.55M 23.55M 22.87M 7.49M 18.68M
EV to EBITDA
0.00 0.00 0.00 0.00 0.00
EV to Sales
13.46 13.46 88.28 25.30 0.00
EV to Free Cash Flow
-7.14 -7.14 -6.80 -7.16 -317.64
EV to Operating Cash Flow
-7.14 -7.14 -6.80 -7.16 -317.64
Tangible Book Value Per Share
0.09 0.09 0.11 0.09 <0.01
Shareholders’ Equity Per Share
0.09 0.09 0.11 0.09 <0.01
Tax and Other Ratios
Effective Tax Rate
0.22 0.22 0.06 >-0.01 1.72
Revenue Per Share
0.02 0.02 <0.01 <0.01 0.00
Net Income Per Share
-0.05 -0.05 -0.06 -0.01 >-0.01
Tax Burden
0.78 0.78 1.00 1.00 1.00
Interest Burden
1.00 1.00 0.94 0.78 1.00
Research & Development to Revenue
2.46 2.46 9.63 1.41 0.00
SG&A to Revenue
1.21 1.21 6.75 2.67 0.00
Stock-Based Compensation to Revenue
0.26 0.26 1.64 0.91 0.00
Income Quality
0.69 0.69 0.82 1.02 0.15
Currency in AUD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis